The global coil-assisted flow diverters market is expected to be valued at USD 283.2 million in 2022. Between 2023 and 2033, this market is expected to generate revenues worth USD 305.01 million and USD 640.42 million, respectively, with a rapidly rising CAGR of 7.7%.
One of the main reasons propelling the coil-assisted flow diverters market is the increasing incidence of brain aneurysms as well as risk factors linked to it as well as the growing trend towards minimally invasive therapies. A few additional factors influencing the market expansion include rising public knowledge of available treatments and government measures to reduce the occurrence of intracranial aneurysms.
Owing to several devices that have been given FDA approval for use in treating cerebral aneurysms, coil-assisted flow diverters have seen more momentum in 2021. The market for embolic coils, which were formerly regarded as the gold standard for the treatment of cerebral aneurysms, is predicted to be decimated by the recent approval of coil-assisted flow diverters.
Coil-assisted flow diverters, which resemble stents, are utilized to embolize cerebral aneurysms. The market for coil-assisted flow diverters is therefore being driven by the rising prevalence of cerebral aneurysms. According to the Ministry of Health, Labor, and Welfare's 2017 Survey, there are about 1.1 million individuals in Japan who have cerebrovascular illnesses, including subarachnoid hemorrhages and cerebral aneurysms.
Also, according to the National Health Service (NHS), 1 in 12,600 persons in England experience a burst brain aneurysm each year. Moreover, roughly 2 million individuals in Germany have had an unruptured intracranial aneurysm, according to research titled Unruptured Intracranial Aneurysms-Pathogenesis and Personalized Treatment that was published in Deutsches Ärzteblatt International in 2020. (IA). Consequently, there is a significant market for coil-assisted flow diverters due to the rising incidence of cerebral aneurysms.
Moreover, obesity, drinking, smoking, and hypertension are associated with the growth of brain aneurysms. As a result, the need for coil-assisted flow diverters is projected to increase as these illnesses become more common. In addition, the world's expanding elderly population, an increase in neurological illnesses linked to it, and technical developments in coil-assisted flow diverters are all expected to boost market expansion.
The coil assisted flow diverters market is divided into two segments based on the kind of aneurysm they treat: narrow-neck and wide-neck aneurysms. Wide-neck bifurcation aneurysms held a bigger market share in 2022, and it is predicted that this category would grow at a faster rate throughout the forecast period.
To treat wide-necked aneurysms, neuro interventionalists are continually creating new methods. The early method for embolizing an aneurysm comprised the use of intraluminal tools, including balloons and stents. Such advances are predicted to create new opportunities for coil assisted flow diverters on the international market.
A paradigm change in the endovascular treatment of the wide-necked aneurysms was brought about by the development of flow-diverting devices. For instance, the research group at the Sree Chitra Thirunal Institute of Medical Science and Technology (SCTIMST) stated in March 2020 that they had created a novel intracranial flow diverter stent for the treatment of brain aneurysms.
Several important stakeholders are concentrating on research initiatives to solve the problems with the available therapeutic choices. A Neqstent Coil-assisted flow diverter designed to treat cerebral aneurysms, for instance, was granted CE mark certification by Cerus Endovascular in April 2020. Wide-necked bifurcation and bifurcation aneurysms are two aneurysm morphologies that the Neqstent is intended to treat.
| Data Point | Key Statistics |
|---|---|
| Expected Market value in 2023 | USD 305.01 Million |
| Expected Market value in 2033 | USD 640.42 Million |
| Growth Rate (2023 to 2033) | 7.7% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Coil assisted flow diverters is a novel adjunctive intrasaccular stent designed for application with embolization coils for the treatment of aneurysms. Coil assisted flow diverters are made of super visible braid elastic matter, and is less restrictive due to the independent maintenance of coil within the aneurysm sac, without the need of parent vessel stabilization.
Coil assisted flow diverter is available as Neqstent coil assisted flow diverter by Cerus Endovascular. Brain Aneurysm Foundation has stated that 6 million people in the U.S are affected with an un-ruptured brain aneurysm and 30,000 are affected with brain aneurysm rupture.
The flow diversion of coil assisted flow diverter functions with embolization coils for aneurysm sac stabilization and healing. It also possesses mesh braid of contour neurovascular system, with memory properties, self-anchoring, stabilizing and less restricting sizing with the help of high precision re-sheathable placement into the aneurysm sac neck.
Coronavirus and lockdown have impacted the global coil assisted flow diverters market by restricting the movement of patients to hospitals and pharmacies for regular visits and diagnosis. Although, lesser impact has been observed in the emergency cardiovascular procedures.
Global coil assisted flow diverters is poised to grow lucratively due to the surging cases of aneurysms including brain and aortic aneurysms, with advancing stent technology. The advanced features of coil assisted flow diverters can treat wide-neck aneurysms and coiling wide-neck aneurysms, which are otherwise difficult to treat with open brain surgery.
The global market drivers of coil assisted flow diverters to include the advanced features of coil assisted flow diverters that allow accessing the untreatable wide-neck brain aneurysm making it is highly accepted by health practitioners.
Also the active research clinical trials success rates and approvals are driving the coil assisted flow diverter market growth. Coil assisted flow diverters are effective minimally invasive safe for anti-platelet therapy and thromboembolic complications and reliable for the closure of aneurysm.
Hospitals clinics and ambulatory surgical centers along with the improved healthcare infrastructure and expenditure growing awareness and government supports are have consolidated the coil assisted flow diverter sales.
However certain restraints restrict the growth spurt of global coil assisted flow diverters market including periprocedural stroke and deaths reported in the poorly selected patients or with procedures.
FDA has issued safety measures and recommendations for the apt use of coil assisted flow diverters for un-ruptured brain aneurysm treatment. Also high cost sophisticated surgical procedures of coil assisted flow diverters and the dearth of skilled professionals are also decelerating the market. Although the overall global coil assisted flow diverters market is expected to grow with its high acceptance demands government’s support and future approvals.
Principal Consultant
The global coil assisted flow diverters market is expected to grow lucratively with its advanced features acceptance by healthcare professionals government favorable policies active research and approvals.
By application type wide-neck bifurcation dominates the coil assisted flow diverters’ applications because of its elasticity to fit within the narrow neck of the Wide-neck aneurysm which is otherwise un-accessible to surgical clippings. By distribution channels hospitals rules the domain of coil assisted flow diverters market with dedicated research and treatment facilities skilled surgeons and availability of the coil assisted flow diverters.
Europe holds the dominance in the global coil assisted flow diverters since Neqstent coil assisted flow diverter is already approved in this region and is actively deployed to meet the rising demand in treatment of aneurysm sac and long term occlusions.
North America holds the second largest coil assisted flow diverter market driven by the advanced healthcare infrastructure research advancements the U.S based key player such as Cerus Endovascular. Asia pacific coil assisted flow diverters market is growing with a gradual growth spurt.
The market is expected to grow in South Asia including China and India and East Asia including Japan driven by the progressing research and healthcare increasing awareness expanding population and rising intracranial diseases.
Latin America is expected growth with a laggard pace however the grow this expected in future on the verge of the current stent market augmentations with elevating research and healthcare. MEA & Africa coil assisted flow diverters market to grow with a stable pace of major contributing countries Israel and South Africa with their progressing research healthcare and awareness.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The key players of global coil assisted flow diverters market include
The research report presents a comprehensive assessment of the market and contains thoughtful insights facts historical data and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies application and industry.
The report is a compilation of first-hand information qualitative and quantitative assessment by industry analysts inputs from industry experts and industry participants across the value chain.
The report provides in-depth analysis of parent market trends macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The global coil assisted flow diverters market is segmented into the types of applications, distribution channels and regions.
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Market Analysis and Forecast 6.1. Applications 6.2. Distribution Channels 7. Global Market Analysis and Forecast, By Applications 7.1. Wide-neck bifurcation aneurysms 7.2. Bifurcation aneurysms 8. Global Market Analysis and Forecast, By Distribution Channels 8.1. Hospitals 8.2. Clinics 8.3. Ambulatory Surgical Centres 9. Global Market Analysis and Forecast, By Region 9.1. North America 9.2. Latin America 9.3. Western Europe 9.4. Eastern Europe 9.5. Asia-Pacific 9.6. Japan 9.7. Middle East and Africa 10. North America Sales Analysis and Forecast, by Key Segments and Countries 11. Latin America Sales Analysis and Forecast, by Key Segments and Countries 12. Western Europe Sales Analysis and Forecast, by Key Segments and Countries 13. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries 14. Asia-Pacific Sales Analysis and Forecast, by Key Segments and Countries 15. Japan Sales Analysis and Forecast, by Key Segments and Countries 16. Middle East and Africa Sales Analysis and Forecast, by Key Segments and Countries 17. Sales Forecast by Applications and Distribution Channels for 30 Countries 18. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 19. Company Profile 19.1. Medtronic 19.2. DePuy Synthes 19.3. Stryker 19.4. MicroPort 19.5. OBEX Medical 19.6. Abbott 19.7. Cardiatis 19.8. ADMEDES 19.9. Penumbra Inc. and Balt
Explore Healthcare Insights
View Reports
Coil Assisted Flow Diverters Market
